We found that in our treated group, over 75 percent of the cancer cells we initially injected were dead or dying, in comparison to only around 25 percent.
Otkrili smo da je u testnoj grupi, preko 75 posto stanica raka koje smo na početku ubrizgali, umrlo ili umire, u usporedbi sa samo oko 25 posto.